BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9360417)

  • 1. Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer.
    Cardone A; Tolino A; Zarcone R; Borruto Caracciolo G; Tartaglia E
    Panminerva Med; 1997 Sep; 39(3):174-7. PubMed ID: 9360417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic significance of desmoplasia in breast carcinoma. A preliminary clinical study].
    Mezi S; Aloise G; Marzullo A; Marchei P; Di Benedetto A; Modica A; Vasaturo F; Modesti M
    G Chir; 1997 May; 18(5):263-8. PubMed ID: 9312252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
    Scorilas A; Talieri M; Ardavanis A; Courtis N; Dimitriadis E; Yotis J; Tsiapalis CM; Trangas T
    Cancer Res; 2000 Oct; 60(19):5427-33. PubMed ID: 11034084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytic infiltration surrounding liver metastases from colorectal cancer.
    Okano K; Maeba T; Moroguchi A; Ishimura K; Karasawa Y; Izuishi K; Goda F; Usuki H; Wakabayashi H; Maeta H
    J Surg Oncol; 2003 Jan; 82(1):28-33. PubMed ID: 12501166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas.
    Ménard S; Tomasic G; Casalini P; Balsari A; Pilotti S; Cascinelli N; Salvadori B; Colnaghi MI; Rilke F
    Clin Cancer Res; 1997 May; 3(5):817-9. PubMed ID: 9815754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].
    Jakić-Razumović J; Corić M; Vrbanec D; Babić D; Hlupić L; Belev B
    Lijec Vjesn; 2005; 127(1-2):3-7. PubMed ID: 16145866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan.
    Wernicke M; Piñeiro LC; Caramutti D; Dorn VG; Raffo MM; Guixa HG; Telenta M; Morandi AA
    Mod Pathol; 2003 Feb; 16(2):99-107. PubMed ID: 12591961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of prognostic factors in premenopausal women with breast cancer.
    Finek J; Holubec L; Topolcan O; Elgrova L; Skalova A; Pecen L
    Anticancer Res; 2007; 27(4A):1893-6. PubMed ID: 17649790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma.
    Liu D; Baltayan A; Naritoku WY; Barr NJ; Young LL; Chaiwun B; Tsao-Wei DD; Groshen SL; Taylor CR; Torloni H; Neville AM; Cote RJ; Imam SA
    Anticancer Res; 2000; 20(3A):1451-61. PubMed ID: 10928056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients.
    Grøndahl-Hansen J; Christensen IJ; Briand P; Pappot H; Mouridsen HT; Blichert-Toft M; Danø K; Brünner N
    Clin Cancer Res; 1997 Feb; 3(2):233-9. PubMed ID: 9815678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of desmoplasia in recurrence of stage II colorectal cancer within five years after surgery and therapeutic implication.
    Crispino P; De Toma G; Ciardi A; Bella A; Rivera M; Cavallaro G; Polistena A; Fornari F; Unim H; Pica R; Cassieri C; Mingazzini PL; Paoluzi P
    Cancer Invest; 2008 May; 26(4):419-25. PubMed ID: 18443963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of ER beta protein correlates with vascular endothelial growth factor and its prognostic significance in human breast cancer.
    Wen XF; Shen Z; Shen ZZ; Nguyen M; Shao ZM
    Oncol Rep; 2002; 9(5):937-44. PubMed ID: 12168051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of intratumoral natural killer cells in gastric carcinoma.
    Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Che X; Iwashige H; Aridome K; Hokita S; Aikou T
    Cancer; 2000 Feb; 88(3):577-83. PubMed ID: 10649250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
    Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer: poor short-term prognosis in cases with moderate lymphocyte infiltration at the tumour edge: a preliminary report.
    Hartveit F
    Oncol Rep; 1998; 5(2):423-6. PubMed ID: 9468572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor HGF lacks prognostic significance in Mexican breast cancer patients.
    Pruefer FG; Unger-Saldaña K; Mohamier L; Ramírez M; Suárez J; Ramirez MT; Maldonado V; Meléndez-Zajgla J
    J Exp Clin Cancer Res; 2006 Sep; 25(3):357-64. PubMed ID: 17167976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of extracapsular extension of axillary lymph node metastases in T1 to T3 breast cancer.
    Neri A; Marrelli D; Roviello F; De Stefano A; Guarnieri A; Pallucca E; Pinto E
    Ann Surg Oncol; 2005 Mar; 12(3):246-53. PubMed ID: 15827817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma.
    Maeshima AM; Niki T; Maeshima A; Yamada T; Kondo H; Matsuno Y
    Cancer; 2002 Dec; 95(12):2546-54. PubMed ID: 12467069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of 70-gene prognosis signature in node-negative breast cancer.
    Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
    Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.